Company Makes Serology Testing More Widely Available in Houston as Coronavirus Cases Continue to Surge
Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its SARS-CoV-2 Multi-Antigen Serology Panel, is now available in Houston. Genalyte’s antibody testing site will be located at Houston’s Toyota Center (1510 Polk St.), with appointments available Monday through Friday from 8 a.m. to 5 p.m.“With COVID-19 cases continuing to rise in Houston, we feel it’s imperative to help meet the demand and crucial need for high-quality, extensive antibody testing in the community,” said Genalyte CEO Cary Gunn. “Determining a person or a population’s level of exposure is not only essential to facilitate research to continue to develop a better understanding of the virus, but also to arm Houstonians with the understanding of current or past exposure to COVID-19. ”Genalyte’s SARS-CoV-2 Multi-Antigen Serology Panel is designed to test for SARS-CoV-2 specific antibodies.The serology test is able to detect the type of antibodies present in a person’s blood. Based on the type of antibodies present, the test may indicate the presence of an active or past infection.Genalyte maintains a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, which ensures test results meet and exceed industry standards for clinical laboratory testing. The Genalyte SARS-CoV-2 serology panel goes through rigorous validation efforts to ensure clinical effectiveness and is processed on the company’s U.S. Food and Drug Administration (FDA) Cleared Maverick™ Diagnostic System. The Genalyte serology test also has a very low false-positive rate—with accuracy exceeding 99 percent.Genalyte’s antibody testing service is meant for people who are no longer experiencing any symptoms and have been symptom-free for at least 14 days. Once a blood sample is drawn, it will be sent to the lab for processing, and results will be available to participants within 24-48 hours. People with active symptoms should contact their doctor to discuss diagnostic testing options.Those interested in being tested for antibodies to the virus can register and book appointments at www.genalytecovid19.com.About Genalyte: Genalyte is a healthcare analytics and diagnostics company that improves patient outcomes and lowers cost with real-time results for physicians and patients. Genalyte delivers rapid, actionable results to doctors through decentralized laboratory testing, backed by remote telehealth oversight and monitoring. For more information, please visit www.genalyte.com.